Carnegie Investment Counsel’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.6M | Buy |
132,112
+6,469
| +5% | +$1.51M | 0.67% | 39 |
|
|
2026
Q1 | $30.7M | Sell |
125,643
-34,449
| -22% | -$8.02M | 0.6% | 48 |
|
|
2025
Q4 | $33.1M | Buy |
160,092
+19,577
| +14% | +$3.87M | 0.61% | 45 |
|
|
2025
Q3 | $26.1M | Sell |
140,515
-1,059
| -0.7% | -$181K | 0.49% | 57 |
|
|
2025
Q2 | $21.6M | Sell |
141,574
-3,037
| -2% | -$467K | 0.43% | 65 |
|
|
2025
Q1 | $22.3M | Buy |
144,611
+15,952
| +12% | +$2.5M | 0.53% | 56 |
|
|
2024
Q4 | $18.6M | Sell |
128,659
-5,175
| -4% | -$802K | 0.53% | 55 |
|
|
2024
Q3 | $21.7M | Sell |
133,834
-437
| -0.3% | -$69.6K | 0.64% | 42 |
|
|
2024
Q2 | $19.6M | Sell |
134,271
-26,383
| -16% | -$3.92M | 0.61% | 44 |
|
|
2024
Q1 | $25.4M | Sell |
160,654
-8,072
| -5% | -$1.28M | 0.79% | 32 |
|
|
2023
Q4 | $26.4M | Sell |
168,726
-9,150
| -5% | -$1.4M | 0.91% | 23 |
|
|
2023
Q3 | $27.7M | Sell |
177,876
-2,080
| -1% | -$343K | 1.06% | 18 |
|
|
2023
Q2 | $29.8M | Buy |
179,956
+1,013
| +0.6% | +$163K | 1.1% | 17 |
|
|
2023
Q1 | $27.7M | Buy |
178,943
+3,400
| +2% | +$549K | 1.11% | 16 |
|
|
2022
Q4 | $31M | Buy |
175,543
+3,988
| +2% | +$689K | 1.33% | 11 |
|
|
2022
Q3 | $28M | Buy |
171,555
+6,658
| +4% | +$1.13M | 1.34% | 11 |
|
|
2022
Q2 | $29.3M | Buy |
164,897
+557
| +0.3% | +$99.2K | 1.32% | 12 |
|
|
2022
Q1 | $29.1M | Buy |
164,340
+2,311
| +1% | +$393K | 1.06% | 18 |
|
|
2021
Q4 | $27.7M | Buy |
162,029
+12,676
| +8% | +$2.08M | 0.91% | 27 |
|
|
2021
Q3 | $24.1M | Buy |
149,353
+2,707
| +2% | +$462K | 0.91% | 27 |
|
|
2021
Q2 | $24.2M | Buy |
146,646
+4,760
| +3% | +$788K | 0.91% | 24 |
|
|
2021
Q1 | $23.3M | Buy |
141,886
+4,329
| +3% | +$700K | 0.98% | 23 |
|
|
2020
Q4 | $21.6M | Buy |
137,557
+2,121
| +2% | +$313K | 0.97% | 23 |
|
|
2020
Q3 | $20.2M | Buy |
135,436
+2,218
| +2% | +$328K | 1.03% | 21 |
|
|
2020
Q2 | $18.7M | Sell |
133,218
-4,448
| -3% | -$648K | 1.08% | 20 |
|
|
2020
Q1 | $18.1M | Sell |
137,666
-1,657
| -1% | -$235K | 1.26% | 15 |
|
|
2019
Q4 | $20.3M | Sell |
139,323
-2,240
| -2% | -$304K | 1.17% | 16 |
|
|
2019
Q3 | $18.3M | Sell |
141,563
-15,517
| -10% | -$2.04M | 1.17% | 19 |
|
|
2019
Q2 | $21.9M | Sell |
157,080
-128
| -0.1% | -$17.7K | 1.42% | 10 |
|
|
2019
Q1 | $22M | Buy |
157,208
+24,420
| +18% | +$3.27M | 1.51% | 9 |
|
|
2018
Q4 | $17.1M | Sell |
132,788
-4,848
| -4% | -$676K | 1.59% | 9 |
|
|
2018
Q3 | $20.1M | Sell |
137,636
-1,479
| -1% | -$197K | 1.65% | 11 |
|
|
2018
Q2 | $17.9M | Buy |
139,115
+9,570
| +7% | +$1.19M | 1.36% | 12 |
|
|
2018
Q1 | $16.5M | Buy |
129,545
+16,776
| +15% | +$2.27M | 1.38% | 12 |
|
|
2017
Q4 | $14.8M | Buy |
112,769
+12,025
| +12% | +$1.67M | 1.32% | 12 |
|
|
2017
Q3 | $14.5M | Buy |
100,744
+110
| +0.1% | +$14.6K | 1.69% | 6 |
|
|
2017
Q2 | $13.3M | Buy |
100,634
+2,246
| +2% | +$287K | 1.62% | 6 |
|
|
2017
Q1 | $12.1M | Buy |
98,388
+2,813
| +3% | +$336K | 1.5% | 11 |
|
|
2016
Q4 | $11.2M | Buy |
95,575
+3,683
| +4% | +$425K | 1.49% | 9 |
|
|
2016
Q3 | $10.9M | Buy |
91,892
+1,575
| +2% | +$191K | 1.57% | 8 |
|
|
2016
Q2 | $11.3M | Buy |
90,317
+11,874
| +15% | +$1.35M | 1.59% | 6 |
|
|
2016
Q1 | $8.49M | Buy |
78,443
+1,740
| +2% | +$180K | 1.3% | 14 |
|
|
2015
Q4 | $8M | Sell |
76,703
-1,015
| -1% | -$102K | 1.39% | 12 |
|
|
2015
Q3 | $7.79M | Buy |
77,718
+2,692
| +4% | +$260K | 1.34% | 19 |
|
|
2015
Q2 | $7.31M | Buy |
75,026
+1,293
| +2% | +$129K | 1.28% | 15 |
|
|
2015
Q1 | $7.41M | Buy |
73,733
+6,169
| +9% | +$627K | 1.28% | 17 |
|
|
2014
Q4 | $7.19M | Buy |
67,564
+1,584
| +2% | +$167K | 1.35% | 13 |
|
|
2014
Q3 | $7.03M | Buy |
65,980
+16,115
| +32% | +$1.67M | 1.4% | 6 |
|
|
2014
Q2 | $5.22M | Sell |
49,865
-1,661
| -3% | -$168K | 1.19% | 24 |
|
|
2014
Q1 | $5.06M | Buy |
51,526
+156
| +0.3% | +$14.5K | 1.33% | 20 |
|
|
2013
Q4 | $4.71M | Buy |
51,370
+121
| +0.2% | +$11.2K | 1.26% | 23 |
|
|
2013
Q3 | $4.44M | Buy |
51,249
+562
| +1% | +$50.4K | 1.37% | 19 |
|
|
2013
Q2 | $4.35M | Buy |
+50,687
| New | +$4.3M | 1.43% | 17 |
|
Other funds holding JNJ
AACR
Carnegie Investment Counsel's JNJ Position: Q2 2026 in Review
Carnegie Investment Counsel increased its Johnson & Johnson (JNJ) stake by 5.1% in Q2 2026, buying an estimated $1.51M and bringing the position to 132,112 shares worth $33.6M. The position accounts for 0.67% of the portfolio, ranked #39.
Carnegie Investment Counsel first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Carnegie Investment Counsel held 132,112 shares of Johnson & Johnson worth $33.6M as of Q2 2026.
- Carnegie Investment Counsel bought 6,469 Johnson & Johnson shares in Q2 2026, an estimated $1.51M.
- Johnson & Johnson made up 0.67% of Carnegie Investment Counsel's portfolio in Q2 2026, its #39 holding.
- Carnegie Investment Counsel first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
- 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.